NORTHVALE, N.J., March 22, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (OTCBB:ELTP) today announced that it has entered into an agreement to develop for a private Hong Kong-based company (the “Customer”) a branded prescription pharmaceutical product.
